Monoclonal Antibody Cured Cancer

This information published here for the benefit of all mankind:Show more

100% Cancer Remission Achieved in ALL Patients in Groundbreaking Study “PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer” June twenty-third, two thousand and twenty-three.; A. Cercek et all. Published in the New England Journal of Medicine.

Dr. Andrea Cercek, one of the lead researchers, said:

“It’s absolutely incredible ... We’ve certainly never seen this before.”

All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody.

This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies.

The authors wrote:

“All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment).